What is Nuvalent Inc (NUVL) stock price today?

Nuvalent Inc (NUVL) currently trades at $105.28 per share. The stock has a market capitalization of $8.09B and a P/E ratio of —x.

Is NUVL stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Nuvalent Inc has a Smart Value Score of 25/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 1/9 and Altman Z-Score is 8.15.

Is Nuvalent Inc financially healthy?

Nuvalent Inc's Piotroski F-Score is 1/9 (weak financial health). The Altman Z-Score of 8.15 places it in the safe zone.

NUVL

Nuvalent Inc

NASDAQ: NUVL · HEALTHCARE · BIOTECHNOLOGY

$105.28

+2.81% today

Updated 2026-05-08

Market cap

$8.09B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-6.06

Dividend yield

—

52W range

$69 – $113

Volume

0.6M

Market cap

$8.09B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-6.06

Dividend yield

—

52W range

$69 – $113

Volume

0.6M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.8

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

8.2

Altman Z-Score

Safe zone

—

Industry rank

—

View all highly rated stocks (75+) →195 stocks currently score above 75

Price targets

Analyst target

$142.37

+35.23%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

4 Strong Buy15 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

+ Altman Z 8.15 — safe zone

Risks

- Piotroski 1/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-73.33M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-73.35M	$-126.22M	$-260.76M	$-425.38M	$-118.70M
EPS	—	—	—	—	$-6.06
Free cash flow	$-64.97M	$-99.74M	$-185.06M	$-275.21M	$-73.33M
Profit margin	—	—	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-04-30	MILLER, DEBORAH ANN	Sale	5,500	—
2026-04-30	MILLER, DEBORAH ANN	Buy	5,500	$6.89
2026-04-30	MILLER, DEBORAH ANN	Sale	4,418	$99.13

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
NUVL	$8.09B	25	4.3	3.0	5.0	6.8	—	Avoid
LLY	$869.41B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$535.63B	59	4.7	9.0	3.3	6.0	-38.45%	Buy
ABBV	$358.55B	63	4.0	8.0	4.0	5.0	-20.52%	Buy
UNH	$335.78B	54	5.3	5.5	7.3	4.8	+42.20%	Buy
AZN	$286.68B	62	6.0	8.5	5.3	5.0	+6.60%	Buy

Smart narrative

Nuvalent Inc trades at $105.28. Our Smart Value Score of 25/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of 8.15, it sits in the safe zone.

Frequently asked questions

What is Nuvalent Inc's stock price?

Nuvalent Inc (NUVL) trades at $105.28.

Is Nuvalent Inc overvalued?

Smart Value Score 25/100 (Grade F, Strong Sell).

What is the price target of Nuvalent Inc (NUVL)?

The analyst target price is $142.37, representing +35.2% upside from the current price of $105.28.

Piotroski F-Score?

1/9 — weak financial health.

Altman Z-Score?

8.15 — safe zone.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-41.20%

Beta1.15

50D MA$101.77

200D MA$95.34

Shares out0.07B

Float0.05B

Short ratio—

Avg volume0.6M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

NUVL vs LLY →NUVL vs JNJ →NUVL vs ABBV →Stock screener →